首頁 > 市場調查報告書 > 製藥

循環系統

到 2030 年北美心臟移植市場預測 - 區域分析 - 按手術類型、類型和最終用戶

市場調查報告書

商品編碼

1510694

到 2030 年北美心臟移植市場預測 - 區域分析 - 按手術類型、類型和最終用戶

North America Heart Transplant Market Forecast to 2030 - Regional Analysis - by Surgery Type, Type, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 68 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美心臟移植市場預計將從2022年的72.521億美元成長到2030年的171.9272億美元。

人工智慧在移植手術的應用推動了北美心臟移植市場

由人工智慧 (AI) 支援的獨特設計系統有助於檢測心臟移植後宿主排斥的早期跡象和嚴重程度。心內膜心肌活體組織切片（EMB）篩檢代表了心臟移植後識別同種異體移植排斥反應的護理標準。 2022年，設計了一種新的人工智慧系統，稱為心臟排斥評估神經估計器（CRANE），它可以與醫療評估結合使用，以實現快速、精確的診斷。 CRANE 也有助於減少宿主體內心臟排斥的存在和嚴重程度的差異。它是一個基於深度學習的人工智慧系統，用於自動評估從 EMB 獲得的十億像素全幻燈片影像。 2020 年，美國國立衛生研究院撥款 320 萬美元用於探索人工智慧在心臟移植方面的能力的研究。借助這筆資助，來自佩雷爾曼醫學院（賓州大學）、凱斯西儲大學、克利夫蘭診所和雪松-西奈醫療中心的研究人員旨在研究導致新心臟排斥的原因以及如何處理它。他們使用人工智慧分析心臟活體組織切片組織影像，找到在新的心臟排斥反應中發揮重要作用的免疫細胞類型。因此，人工智慧在心臟移植手術中的採用可能會在未來幾年為市場帶來新的趨勢。

北美心臟移植市場概況

北美的心臟移植市場分為美國、加拿大和墨西哥。 2022年，北美佔據最大的市場佔有率，市場成長可歸因於老年人口激增、心血管疾病盛行率以及心臟衰竭病例增加。慢性腎臟病發生率的增加和老年人口的增加是促進美國心臟移植市場成長的關鍵因素。根據美國心臟協會提供的資料，美國每年新增約 100 萬心臟衰竭病例，預計到 2030 年將有超過 800 萬人患有心臟衰竭。被診斷出患有早期心臟衰竭。

美國食品藥物管理局 (FDA) 擴大批准各種心臟移植手術和產品。此外，大公司的存在也有利於該國的市場。 2022 年 4 月，TransMedics Group, Inc. 的 OCS Heart 獲得 FDA 上市前批准。

北美心臟移植市場收入及 2030 年預測（百萬美元）

北美心臟移植市場細分

北美心臟移植市場分為手術類型、類型、最終用戶和國家。

根據手術類型，北美心臟移植市場分為原位心臟移植和異位心臟移植。 2022年，原位心臟移植細分市場在北美心臟移植市場中佔據更大佔有率。

從類型來看，北美心臟移植市場分為供體活體心臟和人工心臟。 2022年，供體活體心臟細分市場在北美心臟移植市場中佔據較大佔有率。

根據最終用戶，北美心臟移植市場分為醫院、心臟中心等。 2022年，醫院細分市場在北美心臟移植市場中佔據最大佔有率。

根據國家/地區，北美心臟移植市場分為美國、加拿大和墨西哥。 2022年，美國將主導北美心臟移植市場。

Terumo Corp、Evaheart Inc、Abbott Laboratories、SynCardia Systems LLC、BiVACOR Inc、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc、Jarvik Heart Inc 和 Calon Cardio-Technology Ltd 是北美心臟移植市場上的一些領先公司。

A uniquely designed system backed by artificial intelligence (AI) facilitates the detection of early signs and seriousness of the host rejection post-heart transplantation. The endomyocardial biopsy (EMB) screening signifies the standard of care for identifying allograft rejections after a heart transplant. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. CRANE also helps reduce differences regarding the presence and severity of heart rejection in the host body. It is a deep learning-based AI system for the automated assessment of gigapixel whole-slide images obtained from EMBs. In 2020, the National Institute of Health granted US$ 3.2 million to studies based on the exploration of the capabilities of AI in heart transplants. With this grant, researchers from Perelman School of Medicine (the University of Pennsylvania), Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center aimed to study what causes the rejection of a new heart and how to manage it. They used AI to analyze cardiac biopsy tissue images, finding the types of immune cells that play an instrumental role in new heart rejection. Thus, the adoption of AI in heart transplantation procedures is likely to bring new trends in the market in the coming years.

North America Heart Transplant Market Overview

The heart transplant market in North America is segmented into the US, Canada, and Mexico. North America accounted for the largest market share in 2022, and the market growth can be attributed to an upsurge in the geriatric population, the prevalence of cardiovascular diseases, and an increase in heart failure cases. The increasing incidences of chronic kidney diseases and the rising geriatric population are the key factors contributing to the heart transplant market growth in the US. According to data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030. As per the Health Research Funding Organization, ~555,000 people were diagnosed with the beginning stages of heart failure in the US in 2021. Cardiovascular diseases (CVDs) generally lead to heart failure or terminal heart disease, which bolsters the demand for heart transplants.

The US Food and Drug Administration (FDA) is increasingly approving various heart transplant procedures and products. In addition, the presence of major companies benefits the market in this country. In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart.

North America Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

North America Heart Transplant Market Segmentation

The North America heart transplant market is segmented into surgery type, type, end user, and country.

Based on surgery type, the North America heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the North America heart transplant market in 2022.

In terms of type, the North America heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the North America heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the North America heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held the largest share of the North America heart transplant market in 2022.

Based on country, the North America heart transplant market is segmented into the US, Canada, and Mexico. The US dominated the North America heart transplant market in 2022.

Terumo Corp, Evaheart Inc, Abbott Laboratories, SynCardia Systems LLC, BiVACOR Inc, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, Jarvik Heart Inc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the North America heart transplant market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Heart Transplant Market - Key Industry Dynamics

4.1 Heart Transplant Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Target Disease Incidence
- 4.2.2 Growing Geriatric Population
4.3 Market Restraints
- 4.3.1 High Cost of Surgeries
4.4 Market Opportunities
- 4.4.1 Ongoing Research and Development
4.5 Future Trends
- 4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:

5. Heart Transplant Market - North America Market Analysis

5.1 Heart Transplant Market Revenue (US$ Million), 2020 - 2030
5.2 Heart Transplant Market Forecast and Analysis

6. North America Heart Transplant Market Analysis - Surgery Type

6.1 Overview
6.2 Orthotopic Heart Transplant
- 6.2.1 Overview
- 6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
- 6.3.1 Overview
- 6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Heart Transplant Market Analysis - Type

7.1 Overview
7.2 Donor Live Heart
- 7.2.1 Overview
- 7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
- 7.3.1 Overview
- 7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Ventricular Assisted Device
    - 7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.2 Total Artificial Heart
    - 7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Heart Transplant Market Analysis - End User

8.1 Overview
8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
- 8.3.1 Overview
- 8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Heart Transplant Market - Country Analysis

9.1 North America
- 9.1.1 North American Transplant Market Overview
- 9.1.2 North America Heart Transplant Market Breakdown by Country (2022 and 2030)
  - 9.1.2.1 US: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.1.1 Overview
    - 9.1.2.1.2 United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.1.3 United States Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.1.4 United States Heart Transplant Market Breakdown by Type
    - 9.1.2.1.4.1 United States Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.1.5 United States Heart Transplant Market Breakdown by End User
  - 9.1.2.2 Canada: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Overview
    - 9.1.2.2.2 Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.2.3 Canada Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.2.4 Canada Heart Transplant Market Breakdown by Type
    - 9.1.2.2.4.1 Canada Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.2.5 Canada Heart Transplant Market Breakdown by End User
  - 9.1.2.3 Mexico: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.3.1 Overview
    - 9.1.2.3.2 Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.3.3 Mexico Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.3.4 Mexico Heart Transplant Market Breakdown by Type
    - 9.1.2.3.4.1 Mexico Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.3.5 Mexico Heart Transplant Market Breakdown by End User

10. Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Terumo Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Evaheart Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 SynCardia Systems LLC
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 BiVACOR Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BioVentrix Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Berlin Heart GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 LivaNova Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Jarvik Heart Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About the Insight Partners

簡介目錄圖表

List Of Tables

Table 1. Heart Transplant Market Segmentation
Table 2. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Table 3. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Surgery Type
Table 4. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Type
Table 5. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - End User
Table 6. North America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Country
Table 7. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 8. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 9. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 10. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 11. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 12. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 13. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 14. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 15. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 16. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 17. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 18. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 19. Recent Inorganic Growth Strategies in the Heart Transplant Market
Table 20. Recent Organic Growth Strategies in the Heart Transplant Market

List Of Figures

Figure 1. Heart Transplant Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Heart Transplant Market Revenue (US$ Million), 2020 - 2030
Figure 4. Heart Transplant Market Share (%) - Surgery Type, 2022 and 2030
Figure 5. Orthotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Heterotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Heart Transplant Market Share (%) - Type, 2022 and 2030
Figure 8. Donor Live Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Artificial Hearts Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Ventricular Assisted Device Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Total Artificial Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Heart Transplant Market Share (%) - End User, 2022 and 2030
Figure 13. Hospitals Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Cardiac Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. North America: Heart Transplant Market, by Key Country - Revenue (2022) (US$ Million)
Figure 17. North America Heart Transplant Market Breakdown by Country (2022 and 2030)
Figure 18. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 19. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 20. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 21. Growth Strategies in the Heart Transplant Market